Cargando…

Epithelioid Hemangioendothelioma and Epithelioid Hemangioma: Pazopanib as a Potential Salvage Therapy

Epithelioid hemangioma (EH) and epithelioid hemangioendothelioma (EHE) are both rare vascular tumors. EH tumors are often benign while EHE tumors have moderate malignant potential. Here, we present three unique cases at Soroka Medical Center, two featuring EH of the bone and one presenting EHE of th...

Descripción completa

Detalles Bibliográficos
Autores principales: Yakobson, Alexander, Alguayn, Wafeek, Shalata, Walid, Levin, Daniel, Kian, Tawfeek A., Korngreen, Amir, Gibbs, Rachel, Salah, Mahmuod A., Samueli, Benzion, Lavrenkov, Konstantin, Roisman, Laila C., Dudnik, Yulia, Peled, Nir, Refaely, Yael, Kian, Waleed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7983550/
https://www.ncbi.nlm.nih.gov/pubmed/33776722
http://dx.doi.org/10.1159/000510806
Descripción
Sumario:Epithelioid hemangioma (EH) and epithelioid hemangioendothelioma (EHE) are both rare vascular tumors. EH tumors are often benign while EHE tumors have moderate malignant potential. Here, we present three unique cases at Soroka Medical Center, two featuring EH of the bone and one presenting EHE of the mediastinum. Each case demonstrates distinct treatment challenges due to the rarity of both diseases and lack of established guidelines. We propose three treatment approaches including pazopanib for salvage therapy of EH of the bone and minimally invasive surgical resection which in these cases lead to complete symptom relief and tumor stabilization upheld over time with close follow-up.